PFE · Categories · Upgrades
PFE - Analyst upgrades
Pfizer Inc. (PFE) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for PFE
- Pfizer upgraded by RBC Capital Mkts with a new price targetRBC Capital Mkts upgraded Pfizer from Underperform to Sector Perform and set a new price target of $25.00
- Pfizer upgraded by Argus with a new price targetArgus upgraded Pfizer from Hold to Buy and set a new price target of $35.00
- Pfizer upgraded by Daiwa SecuritiesDaiwa Securities upgraded Pfizer from Neutral to Outperform
- Pfizer upgraded by Jefferies with a new price targetJefferies upgraded Pfizer from Hold to Buy and set a new price target of $39.00 from $38.00 previously
- Pfizer upgraded by Daiwa Securities with a new price targetDaiwa Securities upgraded Pfizer from Neutral to Outperform and set a new price target of $51.00
- Pfizer upgraded by Goldman with a new price targetGoldman upgraded Pfizer from Neutral to Buy and set a new price target of $60.00 from $47.00 previously
- Pfizer upgraded by B of A Securities with a new price targetB of A Securities upgraded Pfizer from Neutral to Buy and set a new price target of $70.00 from $59.00 previously
- Pfizer upgraded by UBS with a new price targetUBS upgraded Pfizer from Neutral to Buy and set a new price target of $60.00 from $52.00 previously
- Pfizer upgraded by DZ Bank with a new price targetDZ Bank upgraded Pfizer from Hold to Buy and set a new price target of $41.00